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AND INTERMITTENT RENAL REPLACEMENT THERAPY
ZBRINJAVANJE AKUTNOG BUBRE@NOG ZATAJENJA 
KONTINUIRANIM I INTERMITENTNIM POSTUPKOM
MARKO ]A]I]*
Descriptors: Acute kidney injury – therapy; Renal replacement therapy – methods
Summary. Acute kidney injury (AKI) is the sudden kidney excretory function loss. Patient data of patients hospitalized on 
intensive care unit from 2009 to 2011 and had to undergo one sort of renal replacement therapy (RRT) – continuous or 
 intermittent – was used. 63 patients were in this study, 46 on continuous RRT (CRRT) and 17 on intermittent RRT (IRRT). 
The aim was to analyze connection between RRT method and outcome, DM type 2 and outcome, ma lignant disease and 
outcome, to analyze whether there is statistically significant difference between these and other para meters (potassium, 
urea, creatinine, blood pressure, age, and sex). Outcome was momentary survival – whether patient did or didn’t survive. 
Results have shown that mortality rate was higher at patients on CRRT. However, these patients were haemodynamically 
unstable compared to patients on IRRT.
Deskriptori: Akutno zatajenje bubrega – lije~enje; Bubre`no nadomjestno lije~enje – metode
Sa`etak. Akutno zatajenje bubrega (AZB) nagli je gubitak ekskretorne funkcije bubrega. Analizirani su podatci bolesnika 
koji su bili hospitalizirani u jedinici intenzivnog lije~enja od 2009. do 2011. godine, kod kojih je do{lo do razvoja AZB-a i 
~ije je stanje bilo takvo da je zahtijevalo primjenu jedne od mehani~kih metoda lije~enja AZB-a – kontinuiranu ili intermi-
tentnu. Obuhva}ena su 63 bolesnika, 46 na kontinuiranoj metodi, 17 na intermitentnoj. Cilj je bio analizirati povezanost 
izme|u metode lije~enja i ishoda, {e}erne bolesti tipa 2 i ishoda, maligne bolesti i ishoda, analizirati postoji li statisti~ki 
zna~ajna razlika izme|u tih i ostalih parametara (kalij, urea, kreatinin, krvni tlak, dob, spol). Ishod je bio trenuta~no 
pre`ivljenje – je li bolesnik pre`ivio ili nije. Rezultati su pokazali da je stopa mortaliteta ve}a kod bolesnika na kontinuira-
noj metodi. Ipak, ti su bolesnici bili hemodinamski nestabilniji u usporedbi s bolesnicima na intermitentnoj metodi.
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Acute kidney injury (AKI) is the sudden loss of an excre-
tory kidney function of previously healthy kidneys which 
cannot be fixed through regulating an extrarenal factors.1 It 
is most often presented with increased serum concentrations 
of creatinine and urea and oliguria (diuresis below 400 mL 
per day), although oliguria doesn’t have to be present (di-
uresis can be 600 mL or more per day).2 AKI can occur be-
cause of circulation disorders, intrinsic kidney damage or 
urinary tract obstruction. Therefore, it can be divided into 
prerenal, renal or intrarenal and postrenal kidney injury. 
Most common cause of acute renal injury is acute tubular 
necrosis.3
Prerenal kidney injury with functional oliguria is featured 
by reduced glomerular filtration and increased tubular reab-
sorption of water and salt. In prerenal AKI, tubules are not 
yet damaged and can react to antidiuretic hormone and al-
dosterone.2 Therefore, urine is typically changed; osmolali-
ty is increased, urea/creatinine plasma ratio is increased and 
urine sodium concentration is reduced.4
Oliguria in acute tubular necrosis is featured by reduced 
tubular function. Urine osmolality becomes more similar to 
plasma osmolality and is lower than 350 mmol/kg.
Electrolytic disbalance often occurs.2 Hyponatremia is 
caused by reduced excretion of water. Intrarenal form of 
AKI is featured by increased sodium concentratin in the 
urin.5 Hyperkalemia is caused by reduced potassium excre-
tion, increased katabolism, acidosis and hypoxia. Mem-
brane potentional disorders are more expressed when hy-
perkalemia occurs more rapid.
Acidosis occurs due to reduced hydrogen ions excretion. 
Their concentration is further increased by sulphate, phos-
phate and organic anions which are released through cell 
katabolism.
Reduced renal excretory function leads to cummulation 
of nitrogenous waste products, urea and creatinine, in blood. 
This state is called azotemia. Creatinine concentration in-
crease depends on state of muscle katabolism and is very 
expressed in AKI caused by rhabdomyolysis.
Cardiovascular system is compromised due to hyper-
volaemia and water and salt retention.6 Hyperkalemia can 
cause arrhytmia.
Neurological disorders include central and peripheral 
nervous system and are caused by uremic toxines, electro-
lytic disbalances and metabolic acidosis.2
Treating AKI can be done in two ways, using renal re-
placement therapy (RRT) or using drug treatment.
RRT includes haemodialysis and haemofiltration. Hae-
modialysis is a process where patient’s blood is pumped 
through an array of membranes. This method is known as 
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intermittent RRT. Through those membranes, blood comes 
into contact with dialysate which flows in the opposite di-
rection of blood. Because of diffusion and concentration 
gradient, plasma components change.
Haemodialysis is adjusted in order to get efficient excre-
tion of nitrogenous waste products and to avoid hypervolae-
mia between the procedures. Average height adult is under-
gone to procedure usually three times a week four to five 
hours per procedure.7 Twice a week dialysis is to be per-
formed only if patient has sufficient renal function.
All the patients who undergo dialysis also undergo an an-
ticoagulant therapy, most often heparin, since blood clots in 
contact with artificial surfaces.
Main complication of the procedure is hypotension. In-
sufficient fluid and volume replacement, excessive fluid re-
moval, venous tone disturbances, autonomous neuropathy 
and left ventricle insufficiency can contribute to it’s oc-
curence.
Haemofiltration means removing plasma water and it’s 
dissolved components (potassium, sodium, urea, creatinine) 
by using convective flow through »high-flux« semipermea-
bile membrane and replacing it with components that fit to 
individual patient. This method is known as continuous 
RRT.
States of AKI where patients had to undergo RRT have 
mortality of 50 to 60%,8 although according to some au-
thors, it can be as high as 90%.9
Drug therapy includes volume replacement and diuretics, 
which can treat non-severe AKI. Still, careless volume re-
placement can cause pulmonary oedema, hypoxia, and need 
for mechanical ventilation.10
Table 1. Patient age












Dob (godine) 68.00 30.00 89.00 62.00 18.00 89.00
Table 2. Sex and distribution by method










N 30 16 46
% of method
% metode 65.2% 34.8% 100.0%
% of total
% ukupnog 47.6% 25.4% 73.0%
IRRT
N 10 7 17
% of method
% metode 58.8% 41.2% 100.0%
% of total 
% ukupnog 15.9% 11.1% 27.0%
Total
Ukupno
N 40 23 63
% of method 
% metode 63.5% 36.5% 100.0%
% of total 
% ukupnog 63.5% 36.5% 100.0%
Table 3. Outcome comparison between methods










N 22 24 46
% of method
% metode 47.8% 52.2% 100.0%
% of total
% ukupnog 34.9% 38.1% 73.0%
IRRT
N 14 3 17
% of method
% metode 82.4% 17.6% 100.0%
% of total
% ukupnog 22.2% 4.8% 27.0%
Total
N 36 27 63
% of method
% metode 57.1% 42.9% 100.0%
% of total
% ukupnog 57.1% 42.9% 100.0%
Table 4. Association between diagnosis of DM type 2 and outcome










N 9 37 46
% of method
% metode 19.6% 80.4% 100.0%
% of total
% ukupnog 14.3% 58.7% 73.0%
IRRT
N 3 14 17
% of method
% metode 17.6% 82.4% 100.0%
% of total
% ukupnog 4.8% 22.2% 27.0%
Total
Ukupno
N 12 51 63
% of method
% metode 19.0% 81.0% 100.0%
% of total
% ukupnog 19.0% 81.0% 100.0%
Table 5. Association between malignant disease and outcome








N 5 41 46
% of method
% metode 10.9% 89.1% 100.0%
% of total
% ukupnog 7.9% 65.1% 73.0%
IRRT
N 3 14 17
% of method
% metode 17.6% 82.4% 100.0%
% of total
% ukupnog 4.8% 22.2% 27.0%
Total
Ukupno
N 8 55 63
% of method
% metode 12.7% 87.3% 100.0%
% of total
% ukupnog 12.7% 87.3% 100.0%
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Therapy also depends on which level an injury has oc-
cured.11
At prerenal AKI, rapid volume replacement is indicated 
since the kidneys are insufficiently perfused. As prerenal 
kidney injury can occur in combination with renal, patient 
should be closely monitored.
If the kidney injury occured on the intrarenal level, pa-
tient should be kept alive until kidney recover spontane-
ously.
Postrenal kidney injury is most often treated surgically, 
by removing the obstruction.
The aim of this study was to analyze association between 
RRT method and outcome, between existence of DM type 2 
and outcome, between existence of malignant disease and 
outcome, to analyze whether there is statistically significant 
difference between these parameters and to analyze if there 
Table 7. Correlation coefficients









r 0.310 0.059 –0.090 0.022
P 0.014 0.646 0.481 0.866
N 63 63 63 63
Table 6. Other parameters








CRRT 46 113.02 27.09
–2.829 0.006




CRRT 46 56.04 16.49
–4.390 <0.001
IRRT 17 77.24 18.35
Potassium
(mmol/L)
CRRT 46 5.00 1.49
1.120 0.267
IRRT 17 4.55 1.18
Urea
(mmol/L)
CRRT 46 32.41 20.93
0.213 0.832




CRRT 46 505.54 364.57
–1.676 0.099
IRRT 17 676.53 344.79
Figure 1. Blood pressure range
Slika 1. Raspon vrijednosti krvnog tlaka kod pacijenata
Figure 3. Serum urea concentration range
Slika 3. Raspon koncentracija uree u serumu pacijenata
Figure 2. Serum potassium concentration range
Slika 2. Raspon koncentracija kalija u serumu pacijenata
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Figure 4. Serum creatinine concentration range
Slika 4. Raspon koncentracija kreatinina u serumu pacijenata
Figure 6. Kidney injury etiology at 
patients on IRRT. MODS: Multiple 
organ dysfunction syndrome
Slika 6. Etiologija bubre`nog zatajenja 
kod pacijenata na intermitentnoj 
metodi. MODS: Multiple organ 
dysfunction syndrome
Figure 5. Kidney injury etiology 
at patients on CRRT. GVHR: Graft 
versus host reaction
Slika 5. Etiologija bubre`nog zatajenja 
kod pacijenata na kontinuiranoj 
metodi. GVHR: Graft versus host 
reaction
is statistically significant difference between other parame-
ters (potassium, urea, creatinine, blood pressure, age, and 
sex). Outcome was momentary survival – whether patient 
did or didn’t survive.
Patients and methods
In this retrospective study, made on Clinical Hospital 
Centre Zagreb, patient histories data of those patients who 
were hospitalized on intensive care unit of Clinical Hospital 
Centre Zagreb from 2009 to 2011 and had to undergo one 
sort of RRT – continuous (CRRT) or intermittent (IRRT) – 
was used. Alltogether there were 63 patients in this study, 
46 on CRRT (group 1), 17 on IRRT (group 2). Data taken 
for the analysis were potassium, creatinine and urea serum 
concentrations and systolic and diastolic blood pressure at 
the moment prior to the start of RRT. Age, sex, AKI etiolo-
gy, history of diabetes mellitus type 2 (DM type 2) and ma-
lignant disease were also obtained.
Excluded from this study were patients with chronic re-
nal failure which was not in exacerbation, patients with ter-
minal state malignant disease and patients who died within 
24 hours upon admission.
The aim of this study was to analyze the association be-
tween RRT method and outcome (methods comparison), to 
analyze if there is outcome difference when patient was di-
agnosed with DM type 2, to analyze if there is outcome dif-
ference when patient was diagnosed with malignant disease, 
to analyze if there is statistically significant difference be-
tween other parameters (potassium, urea, creatinine, blood 
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pressure, age, sex). Outcome was momentary survival – 
wether patient did or did not survive.
Data was analyzed by statistical procedures for testing 
differences and correlations using SPSS 17 (IBM, Somers, 
New York) and MedCalc Software 12.2.1 (Mariakerke, Bel-
gium).
Normal distribution of continuous variable was when di-
aphragmatic and rounded distribution was less than 1. Dis-
tribution regularity was checked using Smirnov-Kolmogo-
rov test. Nominal parameters where shown in form of groups 
and ratios. Student T-test was used to determine the differ-
encies between two independent samples of regular distri-
bution. Mann-Whitney U-test was used to determine differ-
encies between two independent samples of irregular distri-
bution. !2-test was used to determine differencies between 
proportions between two independent samples. Spearman 
"-test for nonparametrical analysis was used to determine 
corrlation between samples. Statistical significance was ac-
cepted with p<0.05.
Results
Table 1. There was no age difference, groups were com-
parable (Z=–1.410; p=0.159).
Table 2. There was no statistically significant difference 
between sex (!2=0.219; p=0.640).
Table 3. There is statistically significant difference be-
tween correlation of method and outcome. Mortality rate 
was higher at patients who underwent CRRT. (!2=6.041, 
p=0.014; OR= 5.09 (95% CI 1.288 – 20.128), p=0.020).
Table 4. There was no association between diagnosis of 
DM type 2 and RRT outcome (!2=0.03; p=0.863).
Table 5. There was no association between diagnosis of 
malignant disease and RRT outcome (!2=0.514; p=0.473).
Table 6. There is statistically significant difference be-
tween systolic and diastolic pressure between the two pa-
tient groups.
Table 7. The only correlation was between outcome and 
method with small correlation coefficient (r). The more of-
ten CRRT was used, the more often patient outcome was 
lethal.
Figure 1. Blood pressure range. S. pressure: Systolic pres-
sure. D. pressure: Diastolic pressure.
Figure 2. Serum potassium concentration range.
Figure 3. Serum urea concentration range.
Figure 4. Serum creatinine concentration range.
Figure 5. Kidney injury etiology at patients on CRRT. 
GVHR: Graft versus host reaction.
Figure 6. Kidney injury etiology at patients on IRRT. 
MODS: Multiple organ dysfunction syndrome.
Discussion
AKI is clinical state characterized by rapid kidney func-
tion detoriation, which is determined by measuring the ex-
creted urine and serum concentrations of urea and creati-
nine. It occurs at 10 to 23% of patients hospitalized on in-
tensive care unit.9
CRRT and IRRT are efficient and safe treatment. Theo-
retical advantges of CRRT are better haemodynamic stabil-
ity and easier fluid removal.12 Prolonged duration of AKI or 
necessity for RRT application are connected with bad prog-
nosis.
AKI is mostly, but not always, reversible and lasts seven 
days to three weeks.13 It can last longer if the cause is intra-
renal, if acute tubular necrosis occured or if patient is in 
sepsis.14 States of AKI where patients had to undergo RRT 
have mortality of 50 to 60%,8 although according to some 
authors, it can be as high as 90%.9
According to current data from most studies about com-
paring RRT, there are no differencies when it comes to pa-
tient survival.9,12,15–18
In this study, correlation between outcome and method 
with not significant correlation coefficient was determined, 
or, the more often CRRT was used, the more often patient 
outcome was lethal. There was statistically significant dif-
ference among the two groups of patients in systolic and 
diastolic blood pressure. Both blood pressure values were 
lower in group 1 (CRRT) than in group 2 (IRRT). A conclu-
sion can be drawn that patients in group 1 were haemody-
namically more unstable and therefore had the higher risk 
for lethal outcome. Should all the patients from group 1 
who had diastolic blood pressure lower than 60 mmHg be 
excluded from the group, number of patients in both groups 
would have been the same, seventeen, and only six patients 
in group 1 would have had a lethal outcome.
Statistically significant difference between age and sex 
between the two groups of patients was not observed in this 
study. Differencies between potassium, urea and creatinine 
serum concentrations prior to the start of RRT were not sta-
tistically significant between the two groups of patients. 
Correlation between diagnosis of DM type 2 or malignant 
disease and RRT outcome was not observed.
Swartz et al. came to similar conclusions in their study. 
According to them, higher patient mortality on CRRT was 
connected with disease severity, not with the choice of RRT 
as such.19
One group of authors established a hypothesis that pa-
tients who underwent CRRT could have some not yet de-
tected morbidity.15
One of the criteria for comparison were costs of the pro-
cedure. Farese et al. came to conclusion that CRRT is more 
expensive compared to IRRT and that hospital personel 
have to spend more time next to patient when patient is on 
CRRT.20
What could affect data in this study is how data were col-
lected. It didn’t run all that well as many patient histories of 
potential candidates were unable to be found. Furthermore, 
number of patients on IRRT is almost three times less com-
pared to ones who were on CRRT.
Conclusion
Results have shown that mortality rate was higher at pa-
tients who were on CRRT (group 1). But, it was also shown 
that these patients were haemodynamically unstable com-
pared to patients who were on IRRT (group 2). Since there 
was no statistically significant difference between other pa-
rameters – serum potassium, urea and creatinine – it sug-
gests that in order to compare the two methods more accu-
rately, only patients with similar haemodynamic status 
should be enrolled in the study.
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